Dr. Jaymin C. Shah is a Senior Research Fellow and Head of Global Biopharmaceutics and Advanced Drug Delivery at Pfizer Inc. He obtained his B.Pharm from the University of Mumbai in 1983 and his Ph.D. in Pharmaceutics from the University of Houston in 1988. He then served as an Associate Professor of Pharmaceutical Sciences (Tenured) from 1988 to 1999 at the Medical University of South Carolina, where he led a lab developing sustained release parenteral delivery systems and modeling of skin transport. He joined Pfizer Inc. in 1999, where he has led formulation groups and project teams supporting the development of various candidates as parenteral/ophthalmic and topical dosage forms, peptide and oligonucleotides development, and research initiatives in parenteral and ophthalmic delivery including depots, sterile suspensions, implants, and nanoparticles. Dr. Shah has been recognized with achievement awards for leadership and innovation in Pfizer. His research interests include parenteral sustained release (depot), nanoparticles, IVIVC, ophthalmic and topical delivery, and parenteral formulation development.